Review Article
PPARs and the Development of Type 1 Diabetes
Table 1
Overview of treatments that promote PPAR expression and prevent autoimmune diabetes in NOD mice.
| Drug | Delivery | Diabetes incidence | Reference |
| Fenofibrate | Diet from age 3 weeks | 0% | [44] | Troglitazone | Oral gavage from age 3 weeks | 22% | [149] | Rosiglitazone | Oral gavage from age 3 weeks | 22% | [149] | Epigallocatechin | Water from age 5 weeks | 25% | [151] | Curcumin | i.p. every other day | 33 % (CYP-induced diabetes) | [153] | Cannabidiol | i.p. age 6-12 weeks | 30% | [155] | Capsaicin | Oral gavage at age 9 or 10 weeks | 20% | [158] | Taurine | Water to pregnant mothers | 40% (after 24 weeks) | [160] | Omega-3 | Diet from age 5 weeks | 33% | [157] | Gluten-free diet | Diet from breeding | 15% | [163] |
|
|